Tempus AI, Inc. Class A Common Stock (TEM) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 60.80
(+22.70%)
Based on the Tempus AI, Inc. Class A Common Stock stock forecast from 10 analysts, the average analyst target price for Tempus AI, Inc. Class A Common Stock is USD 60.80 over the next 12 months. Tempus AI, Inc. Class A Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Tempus AI, Inc. Class A Common Stock is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Tempus AI, Inc. Class A Common Stock’s stock price was USD 49.55. Tempus AI, Inc. Class A Common Stock’s stock price has changed by +21.27% over the past week, -3.51% over the past month and 0% over the last year.
Past 12 monthsNext 12 months
No recent analyst target price found for Tempus AI, Inc. Class A Common Stock
No recent average analyst rating found for Tempus AI, Inc. Class A Common Stock
Company Overview Tempus AI, Inc. Class A Common Stock
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois. Read Less
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical compa...Read More
Frequently Asked Questions About Tempus AI, Inc. Class A Common Stock (TEM) Stock
Based on ratings from 10 analysts Tempus AI, Inc. Class A Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, sell and 5 hold ratings.
Unfortunately we do not have enough data on TEM's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for TEM is USD 60.80 over the next 12 months. The maximum analyst target price is USD 74 while the minimum anlayst target price is USD 45.
Unfortunately we do not have enough data on TEM's stock to indicate if its overvalued.
The last closing price of TEM's stock was USD 49.55.
The most recent market capitalization for TEM is USD 9.00B.
Based on targets from 10 analysts, the average taret price for TEM is projected at USD 60.80 over the next 12 months.
This means that TEM's stock price may go up by +22.70% over the next 12 months.
We can't find any ETFs which contains Tempus AI, Inc. Class A Common Stock's stock.
As per our most recent records Tempus AI, Inc. Class A Common Stock has 2,400 Employees.
Tempus AI, Inc. Class A Common Stock's registered address is 600 West Chicago Avenue, Chicago, IL, United States, 60654.
You can get more information about it from Tempus AI, Inc. Class A Common Stock's website at https://www.tempus.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Tempus AI, Inc. Class A Common Stock (TEM) Stock
Based on ratings from 10 analysts Tempus AI, Inc. Class A Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, sell and 5 hold ratings.
Unfortunately we do not have enough data on TEM's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for TEM is USD 60.80 over the next 12 months. The maximum analyst target price is USD 74 while the minimum anlayst target price is USD 45.
Unfortunately we do not have enough data on TEM's stock to indicate if its overvalued.
The last closing price of TEM's stock was USD 49.55.
The most recent market capitalization for TEM is USD 9.00B.
Based on targets from 10 analysts, the average taret price for TEM is projected at USD 60.80 over the next 12 months.
This means that TEM's stock price may go up by +22.70% over the next 12 months.
We can't find any ETFs which contains Tempus AI, Inc. Class A Common Stock's stock.
As per our most recent records Tempus AI, Inc. Class A Common Stock has 2,400 Employees.
Tempus AI, Inc. Class A Common Stock's registered address is 600 West Chicago Avenue, Chicago, IL, United States, 60654.
You can get more information about it from Tempus AI, Inc. Class A Common Stock's website at https://www.tempus.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TEM !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
